Skip to content
Research/Cognitive Enhancement/Low-Dose Aripiprazole

Low-Dose Aripiprazole

Aripiprazole, typically used as an antipsychotic, is being explored at low doses for potential cognitive enhancement and mood stabilization. Its mechanism involves partial agonism of dopamine D2 and serotonin 5-HT1A receptors, which may support cognitive function and emotional regulation. This could be relevant for longevity by potentially improving mental health and cognitive resilience.

Member access required

Clinical protocols and outcomes data are available to AXIFI Members and Providers.